Anti-TNF Antibodies and Autophagy: A Hidden Nexus for a Successful Therapeutic Response?

被引：0
|
作者：
Genua, Marco [1 ,2 ]
Becker, Christoph [3 ]
Vetrano, Stefania [1 ,4 ]
机构：
[1] Humanitas Res Hosp, IBD Ctr, Rozzano, Italy
[2] Univ Milan, Dept Translat Med, Milan, Italy
[3] Univ Erlangen Nurnberg, Dept Med 1, D-91054 Erlangen, Germany
[4] Humanitas Univ, Dept Biomed Sci, Milan, Italy
来源：
JOURNAL OF CROHNS & COLITIS | 2016年 / 10卷 / 03期
关键词：
CROHNS-DISEASE; CANCER CELLS; ATG16L1; NOD2; GENE; SUSCEPTIBILITY; ASSOCIATION; EVEROLIMUS;
D O I：
10.1093/ecco-jcc/jjv222
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：237 / 238
页数：2
相关论文
共 50 条
  • [31] Immunopharmacological profile and therapeutic perspectives of anti-TNFα-therapies
    Fenner, H
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 1998, 57 (05): : 294 - 297
  • [32] Lower Therapeutic Response to Anti-TNF Agents in African Americans with Inflammatory Bowel Disease
    Owings, Anna H.
    Burstiner, Landen
    Royer, Amor
    Johnson, Jeshanah
    Barr, Madelyn
    Hreish, Yousef
    Bradley, Lauren
    Edwards, Kane
    Brar, Himmat
    Laird, Hannah
    Claggett, Brian
    Liu, Julia
    Glover, Sarah C.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S326 - S327
  • [33] Anti-TNF and anti-IL-17 antibodies—better together!
    Jenny Buckland
    [J]. Nature Reviews Rheumatology, 2014, 10 (12) : 699 - 699
  • [34] Genetic and genomic predictors of anti-TNF response
    Prajapati, Rita
    Plant, Darren
    Barton, Anne
    [J]. PHARMACOGENOMICS, 2011, 12 (11) : 1571 - 1585
  • [35] Anti-TNF trough levels and detection of antibodies to anti-TNF in inflammatory bowel disease: are they ready for everyday clinical use?
    Miheller, Pal
    Kiss, Lajos Sandor
    Lorinczy, Katalin
    Lakatos, Peter Laszlo
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (02) : 179 - 192
  • [36] Effect of Anti-TNF Antibodies on Clinical Response in Rheumatoid Arthritis Patients: A Meta-Analysis
    Wu, Chunxiao
    Wang, Shengxu
    Xian, Peifeng
    Yang, Lu
    Chen, Ying
    Mo, Xianjie
    [J]. BIOMED RESEARCH INTERNATIONAL, 2016, 2016
  • [37] Interest in the addition of azathioprine (AZA) to the switch of anti-TNF in IBD patients in loss of response with undetectable anti-TNF trough levels and anti-drug antibodies: A prospective randomised trial
    Roblin, X.
    Paul, S.
    Boschetti, G.
    Phelip, J. M.
    Del Tedesco, E.
    Berger, A.
    Nancey, S.
    Williet, N.
    Flourie, B.
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S414 - S415
  • [38] Performances of anti-TNFα antibodies as long-term maintenance therapy for ulcerative colitis Response
    Tursi, Antonio
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 : E1107 - E1108
  • [39] CLINICAL EFFICACY TO A SECOND ANTI-TNF THERAPY IS ASSOCIATED WITH THE DEVELOPMENT OF ANTIBODIES AGAINST THE FIRST ANTI-TNF THERAPY IN PATIENTS WITH SPONDYLOARTRHITIS
    Garcia Carazo, S.
    Plasencia, C.
    Pascual Salcedo, D.
    Bonilla Hernan, G.
    Lojo, L.
    Villalba, A.
    Nuno, L.
    del Olmo, L.
    Gil Barato, S.
    Alcocer Amores, P.
    Arribas, F.
    Perez, E.
    Martin Mola, E.
    Balsa, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 250 - 251
  • [40] THE EFFECT OF THERAPEUTIC ANTI-TNF AGENTS ON REVERSE SIGNALING VIA MEMBRANE TNF
    Symons, Antony
    Renshaw, Blair
    Parrelli, Joel
    Sims, John
    [J]. ADVANCES IN TNF FAMILY RESEARCH, 2011, 691 : 719 - 719
12345